Repligen | RGEN - Market Capitalization


Repligen reported $8.35B in Market Capitalization this August of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agilent USD 32.66B 5.2B Mar/2026
Align Technology USD 12.08B 198M Jun/2026
Bio Techne USD 8.18B 987M Mar/2026
BioMarin Pharmaceutical USD 11.58B 712M Aug/2026
Bristol-Myers Squibb USD 117.66B 6.17B Jun/2026
Bruker USD 7.63B 1.54B Aug/2026
Charles River Laboratories USD 13.38B 2.98B Aug/2026
Danaher USD 138.86B 10.4B Jun/2026
Dentsply International USD 2.32B 36M Mar/2026
General Electric Aerospace USD 389.93B 93.44B Jun/2026
Henry Schein USD 11.45B 1.77B Aug/2026
Illumina USD 26.71B 8.84B Jun/2026
IQVIA Holdings USD 42.66B 10.41B Aug/2026
Mettler Toledo International USD 25.82B 278M Jun/2026
OraSure Technologies USD 174M 61M Dec/2025
Pacific Biosciences Of California USD 565M 180M Dec/2025
Pfizer USD 143.89B 5.44B Aug/2026
Repligen USD 7.86B 168M Aug/2026
Revvity USD 13.76B 1.07B Aug/2026
Standard Biotools USD 359M 133M Mar/2026
Thermo Fisher Scientific USD 190.65B 7.99B Jun/2026
Waters USD 23.45B 13.79B Aug/2026
West Pharmaceutical Services USD 25.36B 7.3B Jun/2026